69,727 Shares in Alignment Healthcare, Inc. $ALHC Acquired by Quantbot Technologies LP

Quantbot Technologies LP bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 69,727 shares of the company’s stock, valued at approximately $1,660,000.

Other large investors have also recently bought and sold shares of the company. William Blair Investment Management LLC purchased a new position in Alignment Healthcare during the second quarter worth $184,799,000. Ieq Capital LLC acquired a new position in shares of Alignment Healthcare in the second quarter worth $1,129,000. Allworth Financial LP purchased a new stake in shares of Alignment Healthcare in the second quarter valued at $155,000. Vise Technologies Inc. purchased a new stake in shares of Alignment Healthcare in the second quarter valued at $221,000. Finally, Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Alignment Healthcare during the second quarter valued at $87,794,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ALHC. Barclays dropped their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. JPMorgan Chase & Co. reduced their target price on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, August 4th. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $23.60.

Alignment Healthcare Trading Up 2.1%

Shares of ALHC stock opened at $13.43 on Tuesday. The firm’s 50-day simple moving average is $18.71 and its 200-day simple moving average is $18.73. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. Alignment Healthcare, Inc. has a 1-year low of $12.70 and a 1-year high of $25.12. The firm has a market cap of $2.79 billion, a P/E ratio of 70.69 and a beta of 1.10.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the previous year, the firm earned $0.07 earnings per share. Alignment Healthcare’s revenue was up 31.6% compared to the same quarter last year. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.

Insider Buying and Selling

In other news, insider Mark D. Kent acquired 14,848 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was acquired at an average cost of $13.31 per share, for a total transaction of $197,626.88. Following the acquisition, the insider directly owned 14,848 shares in the company, valued at approximately $197,626.88. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $19.55, for a total value of $586,500.00. Following the completion of the transaction, the president directly owned 947,313 shares in the company, valued at $18,519,969.15. This trade represents a 3.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,009,951 shares of company stock worth $18,597,287 over the last 90 days. Company insiders own 5.20% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.